Why I Vaccinate: Maria Trent, MD, MPH, Associate Professor in Pediatrics at Johns Hopkins Bloomberg School of Public Health, advocates for creating an “HPV-free zone” through vaccination. Dr. Trent speaks to fellow healthcare providers about the importance of vaccinating adolescents against human papillomavirus (HPV).
Cervical Cancer Screening Guidelines
In 2018 updated cervical cancer screening guidelines were issued by the US Preventive Services Task Force (USPSTF). The major change in the current recommendation is that the USPSTF now recommends screening every five years with high-risk HPV testing (hrHPV) alone as an alternative to screening every three years with Pap testing alone among women aged 30 to 65 years. The guidance also includes a recommendation for hrHPV and Pap co-testing every five years for women in the same age group.
- Cervical cancer screening should begin at age 21.
- Most HPV infections acquired in teens and young adults clear up spontaneously, including those caused by high-risk types. It is now recognized that screening young women soon after onset of sexual activity results in large numbers of HPV infections and Pap test abnormalities that can safely be ignored, but that historically have resulted in unnecessary treatment accompanied by preventable anxiety and stress.
- For women ages 20-29, screening with cytology alone every three years
- For women 30 and over:
- Screening every three years with cytology alone
- Screening every five years with cytology/HPV co-testing
- Screening every five years with HPV testing alone
- For women 65 and over: Cervical cancer screening can end for most women at age 65, provided they have a history of adequate screening tests with normal results
- Post-hysterectomy: Screening is not recommended for women of any age after removal of the cervix unless there is a history of significant cervical precancer (CIN2 or higher).
Continuing Medical Education: A 16-Year-Old Boy in the Clinic for a Sports Physical
In collaboration with WebMD and The Yellow Umbrella Organization, ASHA has developed an activity, A 16-Year-Old Boy in the Clinic for a Sports Physical, for pediatricians, nurses, and primary care physicians. The goal is to reinforce knowledge of the indications for HPV vaccination in males. CME/CE credit for is available for physicians and nurses. See more here.
Continuing Medical Education: An 11-Year-Old Girl Due for Vaccinations
Also in collaboration with WebMD and The Yellow Umbrella Organization, ASHA has developed an activity, An 11-Year-Old Girl Due for Vaccinations, for pediatricians, nurses, obstetricians and gynecologists, and primary care physicians. The goal is to provide guidance on responding to human papillomavirus (HPV)-vaccine-hesitant parents. CME/CE credit for is available for physicians and nurses. See more here.
HPV-related Diseases: Separating Fact from Fiction
This activity, done in collaboration with Medscape Education Pediatrics, looks at HPV infections and diseases in males and covers new data in this area. Click here to access this video presentation.
FAQs on HPV for Clinicians
Dr. H. Hunter Handsfield, a clinical professor of medicine at the University of Washington and a leader in STD prevention and research for more than 30 years, answers common questions about HPV in a two-part video series.
Counseling patients on HPV:
A video primer for clinicians on effective patient counseling for HPV and genital warts. The brief video includes talking points on relationships, incidence and prevalence, vaccines, and HPV’s natural history.